---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-26-347315"
form_type: "8-K"
ticker: "OKUR"
cik: "0001637715"
company_name: "OnKure Therapeutics, Inc."
filed_at: "2026-08-12T22:22:46+00:00"
generated_at: "2026-08-13T10:05:37.270130+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# OnKure reprices underwater options to $4.14; ~1.7M shares affected

## Summary
- Board approved repricing of eligible options with exercise price >= $10.00 to $4.14, effective Aug 7, 2026.
- CEO Saccomano: 571,423 options repriced; CMO Agresta: 149,984; CFO Leverone: 141,714.
- Repriced options total ~1.7M shares; original exercise prices ranged $13.99-$24.59.
- Retention requirement: 18 months for senior management, 1 year for others; no change to term, vesting, or share count.

## SEC filing metadata
- accession: 0001193125-26-347315
- form_type: 8-K
- ticker: OKUR
- cik: 0001637715
- company_name: OnKure Therapeutics, Inc.
- filed_at: 2026-08-12T22:22:46+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 5.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1637715/000119312526347315/0001193125-26-347315-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1637715/000119312526347315/okur-20260807.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-26-347315
- JSON: https://secwatch.observer/filing/0001193125-26-347315.json
- Plain text: https://secwatch.observer/filing/0001193125-26-347315.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.